ginsenoside rh2 has been researched along with pyronine in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (pyronine) | Trials (pyronine) | Recent Studies (post-2010) (pyronine) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 266 | 0 | 53 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | pyronine (IC50) |
|---|---|---|---|
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 42 | |
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 26.873 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 16.8 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 16.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; He, J; Liu, J; Lu, M; Sun, X; Sun, Y; Wang, G; Wang, Y; Zhang, J; Zhang, X; Zhou, F | 1 |
1 other study(ies) available for ginsenoside rh2 and pyronine
| Article | Year |
|---|---|
Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Ginsenosides; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Peritonitis; Protein Conformation; Pyronine; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus | 2014 |